At its annual gala on November 12, 2019, the CHPA Educational Foundation will present five new OTC marketing awards, recognizing the first-in-class OTC marketing campaigns of CHPA member companies and their trusted brands. Specific awards will recognize top performers in digital marketing, corporate social responsibility, and innovation.

A diverse panel of judges will anonymously score the nominations and select three finalists for each award. The winners will be announced during the Gala.

Entry Deadline

All entries must be submitted by COB, Friday, August 9. Download the entry information packet for submission details.


  1. Award categories are open to manufacturer or associate CHPA member companies. The entity submitting the entry may be an agency, client, production company studio, or other firm that supported the CHPA member in its OTC marketing campaign.
  2. The OTC marketing campaign must be a U.S.-based campaign.
  3. To be eligible, the entry must have run between August 1, 2018, and July 31, 2019. Qualifying campaigns must have been active for at least part of the eligibility period.
  4. A single campaign may be submitted into multiple award categories; however, a tailored entry and separate set of supporting materials must be submitted for each category entered.
  5. If there are any parts of your entry that should remain confidential (ex: budget), please specify.
  6. If your entry does not include all the award requirements specified, it will not be judged.

The Awards

Best OTC Digital Campaign
Judges will be looking for a campaign that showcases the ability to use one or more digital channels (video, mobile, social media, influencers, etc.) to achieve objectives with the successful delivery of high-quality creative content in the right place, at the right time. High marks will be given to brands that have created content and experiences that captivate and connect with the consumer in the digital space.

Best OTC Corporate Social Responsibility Campaign
Judges will be looking for a campaign that raises awareness or positive sentiment towards a health-related cause/issue in an authentic and effective way. High marks will be given to companies or brands that can showcase community partnerships and/or nonprofit relationships to amplify the campaign for the greater good.

OTC Launch of the Year
Judges will be looking for a new product launch that solves an unmet consumer need through state-of-the-art product innovation and a novel go-to-market strategy to drive performance and achieve objectives. Entries may be for a current brand, new brand, or a line extension to an existing brand. Revitalized/re-launched brands are not eligible for entry.

OTC Innovative Marketing Campaign of the Year on a Budget of Less than $5M
Judges will be looking for a campaign that effectively uses a total marketing spend of less than $5M to deploy novel targeting, creative execution, and content marketing strategies to achieve objectives. High marks will be given to brands that masterfully use consumer insights to craft their campaign. Entries may be for a current brand, new brand, line extension, or revitalized brand.

OTC Innovative Marketing Campaign of the Year on a Budget of More than $5M
Judges will be looking for a campaign that effectively uses a total marketing spend of more than $5M to deploy novel targeting, creative execution, and content marketing strategies to achieve objectives. High marks will be given to brands that masterfully use consumer insights to craft their campaign. Entries may be for a current brand, new brand, line extension, or revitalized brand.

How to Enter

Download the entry information packet for submission details. All entries must be submitted by COB, Friday, August 9.

Download this one-pager to share with team members, agencies, or other stakeholders about the awards.

Judging Panel

David Blair

David Blair, Head of Industry, Healthcare, Google, Inc.
David Blair leads a team responsible for driving thought leadership and business transformation across top pharmaceutical and consumer health companies using data-driven insights, machine learning, search, YouTube, Google Marketing Platform, and Cloud solutions. He began his digital career in 1997 at iVillage as vice president of strategic sponsorships where he pioneered many of the first digital marketing initiatives with Fortune 500 companies including P&G, Coke, Ford, Kimberly Clark, Kellogg’s, and FujiFilm. He moved into the digital health space in 2001 as SVP/group publisher for Johnson & Johnson’s and was SVP of ad sales for Revolution Health, before the merger with EverydayHealth where he was general manager/SVP of provider solutions. He is an active member of the Google Healthcare Advisory Board, named top 40 Healthcare Transformers in the US by Medical Marketing & Media, and is a speaker at global events including the World Economic Forum on Global Health and Cannes Lions Health.

Piyush Chaudhari

Piyush Chaudhari, CEO at sgsco
Piyush Chaudhari joined sgsco from IRI, where he was most recently president of the Americas and global strategy. He is a 20-year veteran of client service, operations and technology and has a proven track record of setting business strategy and driving profitable growth. During his tenure at IRI, Chaudhari oversaw a period of strong customer growth and client retention, having built enduring relationships with leading consumer companies and retailers. Before joining IRI, he was a member of Aon Hewitt's executive committee, involved in setting the firm's direction and ensuring successful execution for its multi-national clients. Prior to Aon Hewitt, Chaudhari was with McKinsey & Co., where he focused on technology and technology strategy.

George Coleman

George Coleman, Senior Vice President of Merchandising, CVS Health
George Coleman’s areas of responsibility include consumer healthcare, beauty and personal care, consumables, general merchandise, and business planning. He oversees all aspects of category management for CVS front-store retail strategy, including assortment, merchandising, pricing and promotion decisions, and supplier relations. Prior to assuming his current role, Coleman led the consumer healthcare business at CVS and prior to that, the CVS store brands business. Before CVS Health, he was a partner with Accenture’s retail strategy consulting practice where over a 15-year tenure with the firm, he advised Fortune 500 companies on marketing, strategy development, pricing, and operational efficiency. Early in his career, he spent two years as a volunteer in the Peace Corps in Guinea-Bissau in West Africa.

Susan Isenberg

Susan Isenberg, Global Sector Chair, Health, Edelman
Susan Isenberg leads Edelman’s global network of more than 600 health experts. In her nearly 30 years as a communications specialist, she has provided strategic counsel for an extensive number of Fortune 500 pharmaceutical and healthcare-related companies. Since joining Edelman in 1993, she has overseen and developed integrated corporate and brand communications programs to support some of the world’s leading health companies, including AstraZeneca, Bayer, Bausch & Lomb, Johnson & Johnson, Merck, Novartis, Pfizer and Roche/Genentech, to name a few. She has also worked on behalf of hospitals and other medical institutions and provided issues and crisis management counsel. Isenberg was managing director of health in Edelman’s New York office for more than eight years. Susan has led several award-winning programs for clients, including Together Rx on behalf of a number of health companies and “Hit Play” for DePuy Synthses. She has served as a member of the Executive Committee of PhAME (Pharmaceutical Advertising and Marketing Excellence) and is an ongoing contributor to health communications publications.

Tom Goodwin

Tom Goodwin, EVP, Head of Innovation, Zenith Media
Tom Goodwin’s role is to understand new technology, behaviors, and platforms and ideate and implement solutions for clients that take advantage of these opportunities. He is also voted the #1 voice in marketing by LinkedIn with over 690,000 followers on the platform. Goodwin recently wrote Digital Darwinism, a book aimed to help companies understand change in the world and to be more optimistic about what technology means for business. An industry provocateur and commentator on the future of marketing and business, he's a columnist for the Guardian, TechCrunch and Forbes and frequent contributor to GQ, Ad Age, Wired, AdWeek, Inc, The World Economic Forum and Digiday. He is a regular guest on i24News’s “Cutting Edge” section and runs a global inspiration series and podcast called “Interesting People in Interesting Times”.

Clarence Lee

Professor Clarence Lee, Assistant Professor at the Johnson Graduate School of Management, Cornell University
Professor Clarence Lee is an assistant professor at the Johnson Graduate School of Management, where he is a Breazzano Family Sesquicentennial Fellow. Professor Lee's research examines the drivers behind consumer adoption, usage, and purchase dynamics of digital goods, where he models consumer behavior using Bayesian statistics, structural econometrics, and machine learning techniques. Digital products and platforms, such as the ones produced by many Silicon Valley and NYC tech start-ups, are increasingly present in almost all consumer interactions. In such settings, understanding consumer choice and the dynamics of engagement and usage become critically important in order to acquire, serve, and retain consumers. He currently teaches digital marketing and data analytics & modeling at both the Ithaca and Cornell Tech campuses. Professor Lee received his doctorate from Harvard Business School and holds undergraduate and graduate degrees in electrical engineering and computer science from MIT. Prior to pursuing graduate studies, he has conducted nanotechnology research at IBM and space system design at MIT Lincoln Laboratory.

Steve Neumann

Steve Neumann, Principal, Cardinal Points Consulting, LLC
Steve Neumann provides marketing consulting and market research services to companies and suppliers in the consumer healthcare, consumer package goods, and pharmaceutical industries. Specialty areas include innovation, new product development, and Rx-to-OTC switch where he serves as strategic advisor or project manager, leading any phase of program development and execution. Prior to forming Cardinal Points Consulting, Neumann led teams dedicated to the discovery and championing of consumer and shopper insights for Bayer Consumer Health in the U.S. He joined Bayer with the acquisition of Merck Consumer Care in October 2014 and led the integration of the Global Marketing Team from Merck into Bayer. He has also led the Consumer Behavior research programs for numerous Rx-to-OTC switches in the U.S. and other markets and has presented to FDA Advisory Committees receiving approval for several switches.

George Quesnelle

George Quesnelle, Senior Strategic Advisor, OTC Commercialization and Optimization, PinneyAssociates
George Quesnelle joined PinneyAssociates in 2009 following his retirement from GlaxoSmithKline (GSK) Consumer Healthcare after 30 years in the pharmaceutical and consumer healthcare products industries. He counsels clients on the business planning process and the Rx-to-OTC switch commercialization process for the switch. He has nearly 30 years of Rx-to-OTC switch experience, with commercial responsibility for some of the most successful switches in the industry, including Nicorette and NicoDerm CQ. In his prior role at GSK, Quesnelle had global commercial responsibility for Rx-to-OTC Switch and for Strategic Initiatives for GSK. From 2004 to 2008, he was President of GSK Consumer Healthcare North America, overseeing $2 billion in consumer business. In 2014, the Consumer Healthcare Products Association awarded him the Ivan D. Combe Lifetime Achievement Award for his contributions to the industry, especially his pioneering work in OTC switch and directly improving self-care for consumers in the US.

M'lou Walker

M’Lou Walker, Chief Executive Officer, Pacific World Corporation
With more than 25 years of experience in the management of OTC, personal care, device, and beauty brands at companies large and established (Pfizer, Warner Lambert), smaller and younger (Adams Respiratory Therapeutics, Matrixx), and her own start-up, M’lou Walker’s career-to-date has shaped her into a deeply experienced, highly qualified executive. With her expertise in management and marketing developed through years in “Big Pharma”, she has created success with large, flagship brands for public companies (Listerine, Mucinex, Zantac), led business and brand turnarounds (Zicam, Pacific World) and been a successful entrepreneur. Beginning in October 2018, she took over the reins at her consulting client, Pacific World Corporation. Prior to her current role and consulting work, Walker served as Chief Executive Officer of Matrixx Initiatives (Zicam) for 6 years, successfully reorganizing the company and setting it back on a growth path. In addition to her managerial experience at public and private companies, Walker has served on the boards of public and private companies as well as non-profit organizations.